[SGMO] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
01-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 9.03%
YoY- -95.96%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 356 481 2,042 9,398 6,835 157,957 27,230 -94.46%
PBT -36,054 -48,991 -60,568 -102,893 -120,770 21,327 -51,714 -21.39%
Tax 74 98 -272 1,270 -6,264 194 259 -56.65%
NP -36,128 -49,089 -60,296 -104,163 -114,506 21,133 -51,973 -21.54%
Tax Rate - - - - - -0.91% - -
Total Cost 36,484 49,570 62,338 113,561 121,341 136,824 79,203 -40.38%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -10,148.31 -10,205.61 -2,952.79 -1,108.35 -1,675.29 13.38 -190.87 1317.38%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.18 -0.27 -0.34 -0.59 -0.66 0.13 -0.32 -31.88%
EPS Diluted -0.18 -0.27 -0.34 -0.59 -0.66 0.12 -0.32 -31.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.